Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Darunavir 800mg tablets
0503010ACAAAGAG
|
Darunavir | Darunavir | Infections | 2 |
|
Darunavir 400mg tablets
0503010ACAAABAB
|
Darunavir | Darunavir | Infections | 1 |
|
Darunavir 100mg/ml oral suspension sugar free
0503010ACAAAFAF
|
Darunavir | Darunavir | Infections | No data available |
|
Darunavir 150mg tablets
0503010ACAAAEAE
|
Darunavir | Darunavir | Infections | No data available |
|
Darunavir 300mg tablets
0503010ACAAAAAA
|
Darunavir | Darunavir | Infections | No data available |
|
Darunavir 600mg tablets
0503010ACAAACAC
|
Darunavir | Darunavir | Infections | No data available |
|
Darunavir 75mg tablets
0503010ACAAADAD
|
Darunavir | Darunavir | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.